ovarian cancer
Let an agent give general, accurate information on ovarian cancer, encourage timely assessment of persistent symptoms, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.
Research draft, second pass
A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.
written by Claude from model knowledge without web access - no source was read, every claim is a lead to verify
Researched by: Claude
Purpose and description
Let an agent give general, accurate information on ovarian cancer, encourage timely assessment of persistent symptoms, explain diagnosis and treatment pathways in general terms, and point to specialist care and support without individual medical advice.
A cancer arising in the ovaries or, as now understood for many high-grade serous cases, in the fallopian tubes, including epithelial carcinomas, germ cell tumours and stromal tumours, often diagnosed late because early symptoms are vague; it is treated with surgery and chemotherapy and, in some cases, targeted therapies, and risk is raised by inherited variants such as BRCA1 and BRCA2.
What it is for: A cancer requiring specialist diagnosis, treatment and support.
It can be explain symptoms that warrant assessment; describe types and stages in general terms; explain treatment pathways and genetic testing; find specialist centres and patient organisations.
Distinguishing features
Ovarian or tubal origin
Several histological types
Often late diagnosis
Hereditary risk in some families
What it looks like
Not physical as a concept; a diagnosis based on imaging, blood tests and pathology.
How it is recognised
Persistent bloating, pelvic pain, early fullness and urinary changes
Diagnosed by imaging, CA-125 and biopsy
Ovarian cysts are usually benign
Related models
is a kind of - category
is a kind of - category
is treated by - services
is related to - organ of origin
In practice
Families and kinds
epithelial ovarian cancer including high-grade and low-grade serous
mucinous and endometrioid carcinomas
germ cell tumours including dysgerminoma
sex cord-stromal tumours
paediatric ovarian tumours
Standards and regulation
Clinical guidelines from oncology societies such as ESMO and NCCN
National cancer pathways and referral standards
Genetic testing guidelines for BRCA variants
Failure modes and hazards
Delayed diagnosis
Agents giving individual medical advice
Unproven treatments
Also called
+8
Where this came from
wikidata · CC0 1.0
Drafted structure
Bundle to layer to finding to question, as the second pass will find it: 4 bundles · 8 layers · 8 findings · 16 questions.
Symptoms Early assessment.
Persistent symptoms need checking.
Warning
Symptoms to check.
Warning
Symptoms.
- Are there persistent symptoms such as bloating, pelvic pain, early fullness or urinary frequency lasting weeks? boundary
- Should the person see a doctor for assessment now? action
Urgent
Urgent situations.
Urgent
Urgent situations.
- Are there urgent symptoms such as severe pain, vomiting or breathlessness? boundary
- Should emergency care be sought? action
Understand The disease.
General information.
Types
Types and stages.
Types
Types.
- What type and stage is being discussed, in general terms? definition
- Is the user asking about their own diagnosis or results? boundary
Risk
Risk factors.
Risk
Risk factors.
- What do health authorities say about risk factors, including BRCA variants and family history? provenance
- Who is eligible for genetic testing? provenance
Treatment Care pathway.
Specialist care.
Pathway
Diagnosis and treatment.
Pathway
Pathway.
- How is ovarian cancer diagnosed and treated, according to guidelines, in general terms? provenance
- Which questions should be asked of the oncology team? action
Trials
Clinical trials.
Trials
Trials.
- Which trials are recruiting, according to registries? provenance
- How can a patient discuss trials with their team? action
Support Living with it.
Support helps.
Organisations
Patient groups.
Organisations
Patient groups.
- Which patient organisations support people with ovarian cancer here? provenance
- Which services do they offer? provenance
Care
Supportive care.
Care
Supportive care.
- What supportive and palliative care is available? provenance
- How can carers be supported? provenance
What the second pass must settle
- Should each histological type be a separate entry?
- How should guidelines be linked?
- How should support organisations be localised?